Wouters, R.; Westrøm, S.; Vankerckhoven, A.; Thirion, G.; Ceusters, J.; Claes, S.; Schols, D.; Bønsdorff, T.B.; Vergote, I.; Coosemans, A.
Effect of Particle Carriers for Intraperitoneal Drug Delivery on the Course of Ovarian Cancer and Its Immune Microenvironment in a Mouse Model. Pharmaceutics 2022, 14, 687.
https://doi.org/10.3390/pharmaceutics14040687
AMA Style
Wouters R, Westrøm S, Vankerckhoven A, Thirion G, Ceusters J, Claes S, Schols D, Bønsdorff TB, Vergote I, Coosemans A.
Effect of Particle Carriers for Intraperitoneal Drug Delivery on the Course of Ovarian Cancer and Its Immune Microenvironment in a Mouse Model. Pharmaceutics. 2022; 14(4):687.
https://doi.org/10.3390/pharmaceutics14040687
Chicago/Turabian Style
Wouters, Roxanne, Sara Westrøm, Ann Vankerckhoven, Gitte Thirion, Jolien Ceusters, Sandra Claes, Dominique Schols, Tina B. Bønsdorff, Ignace Vergote, and An Coosemans.
2022. "Effect of Particle Carriers for Intraperitoneal Drug Delivery on the Course of Ovarian Cancer and Its Immune Microenvironment in a Mouse Model" Pharmaceutics 14, no. 4: 687.
https://doi.org/10.3390/pharmaceutics14040687
APA Style
Wouters, R., Westrøm, S., Vankerckhoven, A., Thirion, G., Ceusters, J., Claes, S., Schols, D., Bønsdorff, T. B., Vergote, I., & Coosemans, A.
(2022). Effect of Particle Carriers for Intraperitoneal Drug Delivery on the Course of Ovarian Cancer and Its Immune Microenvironment in a Mouse Model. Pharmaceutics, 14(4), 687.
https://doi.org/10.3390/pharmaceutics14040687